Causes of Visual Loss in Retinal Disease

• Status: Unknown status
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a study of visual outcomes in retinal disease that seeks to identify the causes of visual loss. This data will be used to predict which patients are at risk of losing vision and how they can be better treated.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Royal Surrey County Hospital; Royal Surrey County Hospital NHS Foundation Trust
• Treatments: Adalimumab; Azathioprine; Cyclosporine; Cyclosporins; Etanercept; Immunosuppressive Agents; Infliximab; Methotrexate; Mycophenolate mofetil; Mycophenolic Acid; Prednisolone

Criteria

Inclusion Criteria:

• patients with a diagnosis of ocular inflammation

• patients with at least 6 months of follow-up

Exclusion Criteria:

• patients without a diagnosis of ocular inflammation

• patients with less than 6 months of follow-up